SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-17-039116
Filing Date
2017-07-31
Accepted
2017-07-31 06:03:29
Documents
27
Period of Report
2017-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v471329_6k.htm 6-K 159512
2 EXHIBIT 99.1 v471329_ex99-1.htm EX-99.1 75409
3 GRAPHIC theader_ex99-1.jpg GRAPHIC 19068
4 GRAPHIC tfooter_ex99-1.jpg GRAPHIC 20502
  Complete submission text file 0001144204-17-039116.txt   1074524

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT glmd-20170630.xml EX-101.INS 71830
6 XBRL TAXONOMY EXTENSION SCHEMA glmd-20170630.xsd EX-101.SCH 11137
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE glmd-20170630_cal.xml EX-101.CAL 24120
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE glmd-20170630_def.xml EX-101.DEF 88314
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE glmd-20170630_lab.xml EX-101.LAB 119937
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE glmd-20170630_pre.xml EX-101.PRE 97541
Mailing Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317
Business Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317 97236938448
Galmed Pharmaceuticals Ltd. (Filer) CIK: 0001595353 (see all company filings)

IRS No.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36345 | Film No.: 17991393
SIC: 2834 Pharmaceutical Preparations